Orkambi Approved for Children Starting at 1 Year
The CF community received some great news this week! Orkambi has been granted expanded use approval in the United States to treat children beginning at 12 months of age.
“Today’s approval is another important step on our journey to reach people of all ages living with cystic fibrosis who may benefit from our medicines,” — Carmen Bozic, MD, and chief medical officer at Vertex
Sorry, there were no replies found.
Log in to reply.